|
Model Number 105-5091-150 |
Device Problem
Break (1069)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/22/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report regarding an echelon microcatheter tip damage.The patient was undergoing treatment for an aneurysm embolization.The accessed vessel was the femoral artery with a vessel diameter of 8mm. it was noted the patient's vessel tortuosity was normal.It was reported that after e10 was shaped, the micro-guidewire led e10 to the neck of the aneurysm and then withdrew the micro-guidewire.Because the position of e10 was not satisfactory, the guidewire was sent into e10 again.It was found that the guidewire did not come out from the distal of e10.After withdrawn from the body, it was found that the tip of e10 was broken.The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).The catheter was flushed as indicated in the ifu.No patient symptoms or further complications were reported as a result of this event.
|
|
Manufacturer Narrative
|
H3.Product analysis: ¿equipment used: video inspection system (m-78210), ruler 200cm (m-83361) ¿ as found condition: the echelon-10 micro catheter was returned for analysis within a shipping box; within a plastic bio-pouch; and within an opened echelon-10 inner pouch.¿ damage location details: upon visual inspection, no damages or irregularities were found with the echelon-10 hub.No bends or kinks were found with the echelon-10 catheter body.The echelon catheter body was found to be broken at ~152.5cm from proximal end.The remaining distal segment of the catheter body was not returned for analysis.Therefore, any contributing factors could not be assessed.No other anomalies were observed.¿ testing/analysis: the total lengths of echelon catheter was measured to be ~152.5cm and usable length was measured to be ~144.5cm.When compared to the product drawing ~2.5cm of the echelon-10 distal catheter segment was found to be missing and not returned.¿ conclusion: based on the device analysis and reported information, the customer¿s report of ¿catheter separation/break¿ was confirmed.However, the root cause for the catheter separation could not be determined.H6.Coding updated based on analysis results.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|